| Literature DB >> 29387815 |
Swati Bhardwaj1,2,3, Anoop Misra2,3,4, Seema Gulati1,2,3, Shajith Anoop1,2,3, Vineet Kumar Kamal5, Ravindra Mohan Pandey5.
Abstract
In view of the increasing prevalence of obesity in largely vegetarian Asian Indians, it is important to research a high protein, low carbohydrate vegetarian diet. The present study was designed to evaluate the effects of a "High Protein Complete (lacto) VEgetaRian Diet (Acronym; 'PACER diet'), on weight, body composition and metabolic profiles in non-diabetic obese Asian Indians living in north India. In this 8-week randomized control trial, 102 vegetarian subjects with body mass index (BMI) >25 kg/m2 were randomized to either a test diet (PACER diet; high protein, high fat and moderately low carbohydrate, lacto-vegetarian diet) or control diet (standard vegetarian diet formulated as the dietary guidelines for Asian Indians) after 4 weeks of diet and exercise run-in period. A standard exercise protocol was followed for both groups. Body weight, BMI, waist circumference (WC), blood pressure, fasting plasma glucose (FPG), fasting serum insulin and lipid profile were assessed before and after the intervention. There was significant weight loss along with improvements in cardio-metabolic risk factors among both the groups post intervention. Percent reductions in the intervention group for weight (6.1± 2.9; p < 0.001), WC (3.9 ± 1.7; p < 0.001), FPG (5.9 ± 3.2; p < 0.001), total cholesterol (10.2 ± 6.3: p < 0.001), serum triacylglycerol (13.6 ± 10.6; p < 0.001) and low-density lipoprotein cholesterol (11.9 ± 7.1; p < 0.001]) were significantly greater than the control diet group. In summary, intervention with a PACER diet (high protein, high fat and moderately low carbohydrate, lacto-vegetarian diet) showed significant improvement in weight loss, body composition and cardio-metabolic profile as compared to a standard vegetarian diet among obese Asian Indians in north India.Entities:
Keywords: Nutrition
Year: 2018 PMID: 29387815 PMCID: PMC5772352 DOI: 10.1016/j.heliyon.2017.e00472
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Fig. 1Flow chart of the study design, explaining the subject enrollment process. Investigations: anthropometry (weight, waist circumference, hip circumference, mid upper arm circumference), biochemical investigations (fasting plasma glucose, serum insulin, lipid profile), DEXA scan, 24 hour dietary recall; *lost to follow-up in control group; shift based job (n = 2), relocation (n = 1); #lost to follow-up in intervention group; relocation (n = 1), lost interest in the study (n = 1).
Menu plan for experimental and control diet*.
| Meals | Experimental diet (PACER diet) | Control diet |
|---|---|---|
| Early Morning | Tea (without sugar), Almonds | Tea (without sugar) |
| Breakfast | Double toned milk | Double toned milk |
| Spinach stuffed | Cauliflower stuffed | |
| Grilled cottage cheese with capsicum and tomatoes | Sautéed cottage cheese and tomato | |
| Mid-morning | Protein supplement | Lemonade (without sugar) |
| Cucumber salad (with lemon dressing) | Fruit Salad (without dressing) | |
| Lunch | Vegetable salad (with lemon dressing) | Vegetable salad (with lemon dressing) |
| Radish stuffed thin | ||
| Green gram whole | Kidney beans | |
| Grilled cottage cheese | Curd | |
| Sautéed mushrooms | Mixed vegetable | |
| Tea | Tea (without sugar) | Tea (without sugar) |
| Roasted groundnuts | Roasted chick pea | |
| Pre-Dinner | Protein supplement | Spinach soup (homemade, without starch and fat/oil) |
| Dinner | Lentil soup | Lentils |
| Soybean granules with beans and tomato | Carrot and pea vegetable | |
| Chapatti |
Experimental diet (PACER diet); Control diet; menu resembling standard Indian dietary pattern and meal combinations.
Double toned milk is obtained by the addition of skim milk powder & water to whole milk, in India, under PFA (Prevention of food adulteration) rules, double toned milk should contain a minimum of 1.5% fat & 9.0% non-fat solids [20].
Chapatti, unleavened flatbread made from wheat flour, a staple in South Asia.
Commercial protein powder 15 g/serving (30 g/d).
Dietary composition of the experimental and control diet*.
| Carbohydrate (%) | 36.6 | 60.0 |
| Protein (%) | 26.9 | 15.0 |
| Fat (%) | 36.5 | 25.0 |
| Vegetable protein (pulses, legumes, nuts) | 8.6 (31.3) | 11.1 (70.2) |
| Soy protein | 4.0 (14.9) | 0.0 (0.0) |
| Protein from dairy sources (Milk and milk products; low fat/double toned milk and milk products) | 7.4 (27.9) | 4.7 (29.8) |
| Protein supplement | 6.9 (25.9) | 0.0 (0.0) |
| Saturated fat | 6.4 (17.4) | 7.8 (30.5) |
| Monounsaturated fat | 10.5 (28.6) | 8.1 (31.6) |
| Polyunsaturated fat | 19.9 (54.0) | 9.6 (37.8) |
¶ values in parenthesis show percent of total protein.
Experimental diet (PACER diet); Control diet (Standard diet); menu resembling standard Indian dietary pattern and meal combinations. Values computed from Nutritive values of Indian Foods [21].
Nutritional profile (including essential amino acid content) for the protein supplement used i.
values in parenthesis show percent of total fat.
Baseline characteristics at randomization.
| Variables | Control group (n = 50) | Intervention group (n = 52) | p value |
|---|---|---|---|
| Age (years) | 38.7 ± 9.9 | 38.9 ± 8.7 | 0.879 |
| Male (%) | 17 (34.0) | 21 (40.4) | 0.505 |
| Female (%) | 33 (66.0) | 31 (59.6) | |
| Medical history | |||
| Hypertension (%) | 14 (28.0) | 17 (32.7) | 0.265 |
| Lifestyle profile | |||
| Smoking (%) | 14 (28.0) | 12 (23.1) | 0.325 |
| Alcohol (%) | 11 (22.0) | 17 (32.7) | 1.463 |
| Nutritional profile | |||
| Energy (Kcal) | 1868.7 ± 204.1 | 1824.7 ± 236.7 | 0.318 |
| Protein (%) | 12.1 ± 1.03 | 11.8 ± 08 | 0.085 |
| Carbohydrate (%) | 57.6 ± 3.2 | 57.3 ± 2.8 | 0.237 |
| Fat (%) | 31.0 ± 3.0 | 30.6 ± 2.8 | 0.411 |
| Physical activity profile | |||
| Metabolic Equivalent of Task (MET) score | 32.9 ± 2.8 | 34.02 ± 3.8 | 0.115 |
Values are presented as Means ± SD, p < 0.05: statistically significant.
none of the participants had any history of heart disease or chronic liver disease.
calculated using Students two-sample t test.
calculated using Pearson chi squared test.
Nutritional information for the low carbohydrate protein supplement used for intervention (PACER) diet#.
| Nutrients | Approximate composition/10 g (1 scoop serving size) |
|---|---|
| Macro-nutrients | |
| Energy | 36 kcal |
| Protein | 8.0 g |
| Carbohydrate | 0.5 g |
| Fat | 0.3 g |
| Minerals | |
| Calcium | 70 mg |
| Iron | 1 mg |
| Essential Amino Acids | |
| Isoleucine | 408 mg |
| Leucine | 696 mg |
| Lysine | 544 mg |
| Methionine(& Cysteine) | 224 mg |
| Phenylalanine (& Tyrosine) | 752 mg |
| Threonine | 320 mg |
| Tryptophan | 104 mg |
| Valine | 432 mg |
| Histidine | 216 mg |
As mentioned on nutrient label of the product (AMWAY Nutrilite protein powder).
Sociodemographic profile of the study participants.
| Variables | Control Group (n = 50) | Intervention Group (n = 52) | p value |
|---|---|---|---|
| Education | |||
| Postgraduate (%) | 54.0 | 38.5 | 0.278 |
| Graduate (%) | 44.0 | 57.7 | |
| Intermediate (%) | 2.0 | 3.9 | |
| Occupation | |||
| Homemaker (%) | 16.0 | 17.0 | 0.867 |
| Service (%) | 52.0 | 53.9 | |
| Business (%) | 14.0 | 9.6 | |
| Student (%) | 2.0 | 3.9 | |
| Monthly household income (INR) | 142500 ± 53664.2 | 135769.2 ± 64141.27 | 0.568 |
| Marital status | |||
| Married (%) | 86.0 | 90.4 | 0.472 |
| Unmarried (%) | 14.0 | 9.6 | |
INR; Indian National Rupee.
Calculated using two-sample t-test.
Calculated using chi squared test.
Nutrition and physical activity profile during the study.
| Control Group (n = 44) | Intervention Group (n = 45) | p value | |
|---|---|---|---|
| Nutritional profile | |||
| Energy (Kcal) | 1443.2 ± 130.4 | 1405.9 ± 127.6 | 0.176 |
| Protein (%) | 14.7 ± 1.6 | 24.9 ± 2.2 | < 0.001 |
| Carbohydrate (%) | 59.3 ± 2.7 | 38.5 ± 3.1 | < 0.001 |
| Fat (%) | 26.1 ± 1.7 | 36.6 ± 2.4 | < 0.001 |
| Physical Activity profile | |||
| Metabolic Equivalent of Task (MET) | 36.5 ± 2.8 | 37.5 ± 4.1 | 0.202 |
Calculated using Student’s two sample t-test.
Comparison of anthropometric and biochemical parameters pre- and post- intervention between the two diet groups.
| Intention to treat analysis | Per Protocol Analysis | |||||||
|---|---|---|---|---|---|---|---|---|
| Variables | Control group | Intervention groupǁ (n = 52) | Difference | p-value | Control group | Intervention group | Difference | p-value |
| Weight (kg) | ||||||||
| Pre-intervention | 85.2 ± 10.4 | 83.8 ± 10.4 | 0.49 | 85.8 ± 10.8 | 83.5 ± 10.9 | 0.325 | ||
| (Week 0) | ||||||||
| Post-intervention | 82.7 ± 9.9 | 78.9 ± 10.2 | 0.06 | 82.9 ± 10.2 | 77.9 ± 10.4 | 0.027 | ||
| (Week 8) | ||||||||
| % Change | 2.9 ± 1.7 | 6.1 ± 2.9 | −3.2 (−4.1 to −2.3) | <0.001 | 3.4 ± 1.3 | 7.1 ± 1.9 | −3.7 (−4.4 to −2.9) | <0.001 |
| BMI (kg/m2) | ||||||||
| Pre-intervention (Week 0) | 31.2 ± 2.9 | 31.5 ± 3.1 | 0.6 | 31.2 ± 3.1 | 31.1 ± 3.1 | 0.887 | ||
| Post-intervention | 30.3 ± 2.9 | 29.7 ± 3.2 | 0.35 | 30.2 ± 2.9 | 29.0 ± 2.9 | 0.074 | ||
| (Week 8) | ||||||||
| % Change | 2.9 ± 1.6 | 5.7 ± 2.6 | −2.9 (−3.7 to −2.0) | <0.001 | 3.3 ± 1.3 | 6.6 ± 1.7 | −3.3 (−3.9 to −2.9) | < 0.001 |
| Waist circumference (cm) | ||||||||
| Pre-intervention | 104.1 ± 5.7 | 102.7 ± 5.9 | 0.23 | 103.8 ± 5.7 | 103.2 ± 5.9 | 0.645 | ||
| (Week 0) | ||||||||
| Post-intervention (Week 8) | 101.9 ± 5.9 | 98.7 ± 5.8 | 0.01 | 101.4 ± 5.7 | 98.7 ± 5.9 | 0.034 | ||
| % Change | 2.1 ± 1.1 | 3.9 ± 1.7 | −1.8 (−2.3 to −1.2) | <0.001 | 2.4 ± 0.9 | 4.4 ± 0.9 | −2.1 (−2.4 to −1.7) | < 0.001 |
| Hip circumference (cm) | ||||||||
| Pre-intervention | 110.0 ± 4.6 | 108.8 ± 6.3 | 0.26 | 110.3 ± 4.7 | 109.5 ± 6.5 | 0.507 | ||
| (Week 0) | ||||||||
| Post-intervention (Week 8) | 108.1 ± 4.6 | 105.5 ± 6.1 | 0.01 | 108.1 ± 4.8 | 105.6 ± 6.4 | 0.041 | ||
| % Change | 1.7 ± 0.9 | 3.0 ±1.4 | −1.3 (−1.8 to −0.8) | <0.001 | 1.9 ± 0.7 | 3.5 ± 0.8 | −1.5 (−1.9 to −1.2) | <0.001 |
| Mid upper arm circumference (cm) | ||||||||
| Pre-intervention (Week 0) | 37.3 ±3.01 | 36.4 ± 3.64 | 0.18 | 37.3 ± 3.1 | 36.8 ± 3.7 | 0.47 | ||
| Post-intervention (Week 8) | 36.4 ± 2.8 | 34.8 ± 3.4 | 0.01 | 36.4 ± 2.9 | 34.9 ± 3.5 | 0.046 | ||
| % Change | 2.2 ± 1.4 | 4.3 ± 2.2 | −2.1 (−2.8 to −1.3) | <0.001 | 2.5 ± 1.1 | 4.9 ± 1.6 | −2.4 (−2.9 to −1.8) | <0.001 |
| Body fat percent (%) | ||||||||
| Pre-intervention (Week 0) | 45.4 ± 3.1 | 46.5 ± 2.4 | 0.06 | 45.3 ± 3.3 | 46.3 ± 2.5 | 0.101 | ||
| Post-intervention (Week 8) | 44.9 ± 3.2 | 45.7 ± 2.3 | 0.18 | 44.7 ± 3.3 | 45.4 ± 2.3 | 0.258 | ||
| % Change | 1.0 ± 0.9 | 1.6 ± 0.9 | −0.6 (−0.9 to −0.2) | 0 | 1.2 ± 0.8 | 1.9 ± 0.7 | −0.7 (-0.9 to −0.4) | < 0.001 |
| Systolic blood pressure (mmHg) | ||||||||
| Pre-intervention (Week 0) | 136.1 ± 11.4 | 133.4 ± 12.1 | 0.25 | 136.8 ± 11.7 | 134 ± 12.4 | 0.276 | ||
| Post-intervention (Week 8) | 134.3 ± 10.7 | 129.7 ± 11.2 | 0.03 | 134.8 ± 10.9 | 129.8 ± 11.3 | 0.035 | ||
| % Change | 1.2 ± 1.9 | 2.8 ± 1.8 | −1.53 (−2.28 to −0.78) | <0.001 | 1.4 ± 2.07 | 3.1 ± 1.6 | −1.7 (-2.5 to −0.9) | < 0.001 |
| Diastolic blood pressure (mmHg) | ||||||||
| Pre-intervention (Week 0) | 83.9 ± 5.8 | 85.9 ± 5.1 | 0.07 | 83.8 ± 5.7 | 86.2 ± 5.0 | 0.036 | ||
| Post-intervention (Week 8) | 83.6 ± 5.4 | 85.2 ± 4.5 | 0.11 | 83.4 ± 5.2 | 85.3 ± 4.6 | 0.065 | ||
| % Change | 0.3 ± 1.8 | 0.8 ± 1.9 | −0.42 (−1.16 to 0.32) | 0.26 | 0.5 ± 1.8 | 1.0 ± 1.9 | −0.6 (−1.3 to 0.2) | 0.165 |
| Fasting plasma glucose (mg/dL) | ||||||||
| Pre-intervention (Week 0) | 99.9 ± 10.6 | 97.5 ± 9.5 | 0.23 | 100.3 ± 10.8 | 97.2 ± 9.7 | 0.16 | ||
| Post-intervention (Week 8) | 96.6 ± 9.8 | 91.7 ± 9.6 | 0.01 | 96.6 ± 10.2 | 90.8 ± 9.6 | 0.007 | ||
| % Change | 3.2 ± 2.7 | 5.9 ± 3.2 | −2.7 (−3.9 to −1.6) | <0.001 | 3.7 ± 2.4 | 6.7 ± 2.6 | −2.9 (−4.1 to −1.9) | <0.001 |
| Fasting serum insulin (mU/L) | ||||||||
| Pre-intervention (Week 0) | 16.9 ± 6.1 | 17.0 ± 6.3 | 0.89 | 16.2 ± 5.9 | 17.1 ± 6.6 | 0.514 | ||
| Post-intervention (Week 8) | 15.4 ± 5.9 | 15.4 ± 6.0 | 0.98 | 14.6 ± 5.4 | 15.2 ± 6.2 | 0.605 | ||
| % Change | 8.0 ± 10.5 | 10.5 ± 7.3 | −2.5 (−6.0 to 1.0) | 0.16 | 8.9 ± 10.8 | 11.7 ± 6.9 | −2.8 (−6.7 to 0.9) | 0.145 |
| HOMA-IR | ||||||||
| Pre-intervention (Week 0) | 4.2 ± 1.6 | 4.1 ± 1.5 | 0.85 | 4.0 ± 1.5 | 4.1 ± 1.6 | 0.823 | ||
| Post-intervention (Week 8) | 3.7 ± 1.4 | 3.5 ± 1.4 | 0.51 | 3.5 ±1.3 | 3.42 ± 1.4 | 0.833 | ||
| % Change | 10.9 ± 10.3 | 15.8 ± 8.0 | −4.9 (−8.5 to −1.2) | 0.009 | 12.4 ± 10.2 | 17.7 ± 6.7 | −5.4 (−8.9 to −1.7) | 0.004 |
| Total cholesterol (mg/dL) | ||||||||
| Pre-intervention (Week 0) | 177.1 ± 44.6 | 174.7 ± 38.6 | 0.77 | 181.7 ± 42.8 | 174 ± 39.1 | 0.373 | ||
| Post-intervention (Week 8) | 167.3 ± 42.6 | 156.9 ± 36.8 | 0.19 | 170.6 ± 41.8 | 154.1 ± 36.1 | 0.049 | ||
| % Change | 5.4 ± 4.8 | 10.2 ± 6.3 | −4.8 (−7.0 to −2.6) | <0.001 | 6.2 ± 4.6 | 11.5 ± 5.6 | −5.3 (−7.5 to −3.2) | <0.001 |
| Serum triacylglycerol (mg/dL) | ||||||||
| Pre-intervention (Week 0) | 139.9 ± 36.3 | 140.9 ± 34.8 | 0.89 | 140.5 ± 37.3 | 138.4 ± 33.1 | 0.779 | ||
| Post-intervention (Week 8) | 129.9 ± 31.4 | 121.1 ± 32.0 | 0.16 | 130.3 ± 32.47 | 115.8 ± 27.1 | 0.025 | ||
| % Change | 6.4 ± 6.2 | 13.6 ± 10.6 | −7.2 (−10.6 to −3.8) | 6.6 ± 5.8 | 15.6 ± 10.0 | −8.9 (−12.4 to −5.5) | <0.001 | |
| <0.001 | ||||||||
| HDL-c (mg/dL) | ||||||||
| Pre-intervention (Week 0) | 44.3 ± 9.5 | 42.4 ± 9.1 | 0.32 | 44.9 ± 9.8 | 42.7 ± 9.4 | 0.262 | ||
| Post-intervention (Week 8) | 43.2 ± 8.6 | 41.9 ± 8.1 | 0.42 | 43.8 ± 8.9 | 42.2 ± 7.9 | 0.369 | ||
| % change | 1.9 ± 5.9 | 0.6 ± 8.2 | 1.4 (−1.5 to 4.2) | 0.34 | 2.1 ± 6.3 | 0.2 ± 8.5 | 1.8 (−1.3 to 5.0) | 0.251 |
| LDL-c (mg/dL) | ||||||||
| Pre-intervention (Week 0) | 106.1 ± 31.2 | 100.9 ± 26.01 | 0.36 | 110.1 ± 28.8 | 100.4 ± 23.6 | 0.085 | ||
| Post-intervention (Week 8) | 100.5 ± 29.1 | 89.4 ± 26.4 | 0.05 | 103.6 ± 27.67 | 87.7 ± 22.8 | 0.004 | ||
| % Change | 4.9 ± 5.3 | 11.9 ± 7.1 | −7.0 (−9.5 to −4.6) | <0.001 | 5.9 ± 3.7 | 13.1 ± 6.4 | −7.1 (−9.3 to −4.9) | <0.001 |
| VLDL-c (mg/dL) | ||||||||
| Pre-intervention (Week 0) | 27.9 ± 7.3 | 28.2 ± 6.9 | 0.89 | 28.1 ± 7.5 | 27.7 ± 6.6 | 0.779 | ||
| Post-intervention (Week 8) | 25.9 ± 6.3 | 24.2 ± 6.4 | 0.16 | 26.1 ± 6.5 | 23.2 ± 5.4 | 0.025 | ||
| % Change | 6.4 ± 6.2 | 13.7 ± 10.6 | −7.2 (−10.6 to −3.8) | <0.001 | 6.6 ± 5.8 | 15.6 ± 10.0 | −8.9 (−12.4 to −5.5) | <0.001 |
BMI, Body mass index; HDL-c, high density lipoprotein cholesterol; HOMA-IR, Homeostasis model assessment for insulin resistance; LDL-c, low density lipoprotein cholesterol; VLDL-c, Very low density lipoprotein cholesterol.
Intention to treat analysis was the primary analysis, baseline observations were carried forward for subjects with missing values.
Per protocol analysis, included all compliant participants.
Control group; following standard diet.
Intervention group; following “High Protein Complete (lacto) VEgetaRian” (PACER) diet.
Values are means ± SD.
Difference calculated using Student’s two-sample t-test between the post intervention percent changes of the two groups; 95% CI in parentheses.
Student’s two sample t-test was used to compare difference in mean values between the two groups.
Percent change was calculated between baseline and post intervention values for each group (values presented as %).
The value of HOMA-IR was calculated using the following equation: fasting serum insulin [mU/L] × fasting plasma glucose [mg/dL]/405 [20] The effect size and its 95% CI (mean percentage reduction in the intervention group-control group) was statistically significant for the following parameters: weight: −3.2 (−4.1 to −2.3); BMI: −2.9 (−3.7 to −2.0); WC: −1.8 (−2.3 to −1.2); HC: −1.3 (−1.8 to −0.8) and MUAC: −2.1 (−2.8 to −1.3).
Fig. 2Changes in outcome variables between intervention and control group after 8 week intervention. Intervention group, participants following high Protein Complete (lacto) VEgetaRian diet (PACER diet); Control group, participants following standard diet. Values represent mean unit change (reduction) ± SD. BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HC, hip circumference; HDL-c, high density lipoprotein-cholesterol; LDL-c, low density lipoprotein-cholesterol; MUAC, mid upper arm circumference; SBP, systolic blood pressure; TC, total cholesterol; TAG, serum triacylglycerol; VLDL-c, very low density lipoprotein-cholesterol; WC: waist circumference.